Related references
Note: Only part of the references are listed.Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity
Yassamine Bentata
ARTIFICIAL ORGANS (2020)
Tacrolimus in adult hematopoietic stem cell transplantation
Yuan Gao et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice
Fawzy Elbarbry
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2018)
Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality
Colombe Saillard et al.
BONE MARROW TRANSPLANTATION (2018)
Renal dysfunction following bone marrow transplantation
Stephan Kemmner et al.
JOURNAL OF NEPHROLOGY (2017)
The Nephrotoxicity of Vancomycin
E. J. Filippone et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Optimizing the Clinical Use of Vancomycin
Rocio Alvarez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations
J. T. Tang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Renal Complications of Hematopoietic-Cell Transplantation
Sangeeta Hingorani
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Review of vancomycin-induced renal toxicity: an update
Oluwatoyin Bamgbola
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2016)
Acute Kidney Injury in Hematopoietic Stem Cell Transplantation: A Review
Vinod Krishnappa et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY (2016)
Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients
N. Shingai et al.
BONE MARROW TRANSPLANTATION (2015)
Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases
Ryo Nasu et al.
ANNALS OF HEMATOLOGY (2014)
Preparative Regimen Dosing for Hematopoietic Stem Cell Transplantation in Patients with Chronic Kidney Disease: Analysis of the Literature and Recommendations
Megan N. Bodge et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors
Minoru Ando et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Acute Kidney Injury in Hematopoietic Cell Transplantation
Amy Kogon et al.
SEMINARS IN NEPHROLOGY (2010)
Organ crosstalk: the role of the kidney
Xiang Li et al.
CURRENT OPINION IN CRITICAL CARE (2009)
Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: Epidemiology, pathogenesis, and treatment
Sangeeta Hingorani
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Renal dysfunction in allogeneic hematopoietic cell transplantation
CR Parikh et al.
KIDNEY INTERNATIONAL (2002)
Share Paper
